MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$644,759K
(-39.06%↓ Y/Y)
Income tax benefit
-$136K
(87.93%↑ Y/Y)
Loss before income
tax benefit
-$644,895K
(-38.75%↓ Y/Y)
Other income, net
$3,237K
(-77.23%↓ Y/Y)
License And Service
$74,256K
(26.96%↑ Y/Y)
Grant
$425K
(21.08%↑ Y/Y)
Loss from operations
-$648,132K
(-35.31%↓ Y/Y)
Total revenue
$74,681K
(26.92%↑ Y/Y)
Total operating costs
and expenses
$722,813K
(34.39%↑ Y/Y)
Research and development
$475,271K
(51.16%↑ Y/Y)
General and
administrative
$176,589K
(-0.90%↓ Y/Y)
Cost of revenue
$70,953K
(56.84%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)